Currax Pharmaceuticals rolled out SuperAgents, built on the ACTO life-sciences sales platform, to help reps retrieve approved clinical references and policies during HCP visits. Currax reports a 99% reduction in time-to-answer, a sixfold increase in daily usage per rep, and about 75% of its sales force using it consistently (MM+M).
Reported outcomes
Outcomes are reported exactly as stated by the source; we have not independently audited them.
How it works
- Reps ask questions conversationally; the tool retrieves approved clinical reference documents, policy documents, and operational guides.
- Supports sales practice and HCP strategy discussions.
- Guardrails follow medical and legal team rules on what can be said about products.
Risks & compliance
- Promotional compliance: answers must stay within approved, on-label materials
- Company-reported figures relayed by trade press
Healthcare cases cover operational and commercial workflows. Nothing here is medical advice or a claim about a device's or drug's efficacy.
Casefile: MedTech angle
Direct analog for device reps: instant, compliant answers to unexpected clinician questions in the field.
Editor's notes
- Figures are company-reported to MM+M; graded A because the source is independent trade press, per rubric.
Sources
“This results in expediency, Dreher says, with Currax clocking a 99% reduction in time-to-answer for reps.”Currax Pharmaceuticals is using AI to deploy ‘super agents’ in sales
Grade rationale: Named organization with a quantified outcome reported by an independent source. Automated check on Oct 17, 2026: 1/1 quotes and 2/2 outcome claims matched the source. Compiled by the Agent Casefile research desk (AI-assisted; see methodology). Spot an error? Request a correction.
